WallStreetZenWallStreetZen

NASDAQ: VTVT
Vtv Therapeutics Inc Stock Ownership - Who owns Vtv Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Vtv Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Paul J. SekhriPres CEO and Exec Chairperson2024-11-181,844$16.96
$31.27kBuy
Paul J. SekhriPres CEO and Exec Chairperson2024-11-151,778$16.88
$30.01kBuy
Paul J. SekhriPres CEO and Exec Chairperson2024-11-151,378$16.35
$22.53kBuy

1 of 1

VTVT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VTVT insiders and whales buy or sell their stock.

VTVT Shareholders

What type of owners hold Vtv Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ronald O. Perelman1,220.21%38,919,878$766.72MInsider
G42 Investments Ai Holdings Rsc Ltd325.63%10,386,274$204.61MInsider
Tahnoon Bin Zayed S. Alnahyan325.63%10,386,274$204.61MInsider
Samsara Biocapital GP LLC6.48%206,784$4.07MInsider
Samsara Biocapital LLC6.48%206,784$4.07MInstitution
Srinivas Akkaraju6.48%206,784$4.07MInsider
Fmr LLC5.59%178,200$3.51MInstitution
Baker Bros Advisors LP4.46%142,135$2.80MInsider
Baker Bros Advisors LP3.05%97,314$1.92MInstitution
Paul G. Savas2.88%91,781$1.81MInsider

1 of 3

VTVT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VTVT0.90%99.10%Net Buying
VANI3.47%96.53%Net BuyingNet Buying
IFRX21.89%0.00%
ANL0.05%0.00%
BMEA57.06%42.94%Net Buying
View Top Biotech Stocks

Vtv Therapeutics Stock Ownership FAQ

Who owns Vtv Therapeutics?

Vtv Therapeutics (NASDAQ: VTVT) is owned by 17.29% institutional shareholders, 1,898.14% Vtv Therapeutics insiders, and 0.00% retail investors. Ronald O. Perelman is the largest individual Vtv Therapeutics shareholder, owning 38.92M shares representing 1,220.21% of the company. Ronald O. Perelman's Vtv Therapeutics shares are currently valued at $766.72M.

If you're new to stock investing, here's how to buy Vtv Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.